https://www.selleckchem.com/products/4-Methylumbelliferone(4-MU).html 58 95% CI (1.01;2.46)) and sensory neuropathy (odds ratio 2.46 (1.67;3.63)), larger retinal arteriolar diameters (difference 4.29µm (1.22;7.36)) and less retinal arteriolar dilatation (difference - 0.74% (- 1.22; - 0.25)). In women, these associations were numerically in the same direction, but generally not statistically significant (odds ratios 1.71 (0.90;3.25) and 1.22 (0.75;1.98); differences 0.29µm (- 3.50;4.07) and - 0.52% (- 1.11;0.08), respectively). Interaction analyses revealed no consistent pattern of *** differences in the associations of either prediabetes or type 2 diabetes or glycemia with microvascular complications or retinal measures. The prevalence of advanced-stage complications was too low for evaluation. Our findings show that women with type 2 diabetes are not disproportionately affected by early microvascular complications. Our findings show that women with type 2 diabetes are not disproportionately affected by early microvascular complications. Neonatal encephalopathy due to acute perinatal asphyxia is a major cause of perinatal brain damage. Moderate to severe neonatal encephalopathy is associated with high mortality and morbidity rates. However, the neurodevelopmental outcomes in neonates with mild neonatal encephalopathy are unclear. The primary aim of this single-center observational study was to assess the short-term outcomes in term neonates with mild neonatal encephalopathy due to perinatal asphyxia. A secondary aim was to identify predictors of poor prognosis by identifying the characteristics of these infants according to their short-term outcomes. We retrospectively investigated all infants with perinatal asphyxia at Tokyo Metropolitan Children's Medical Center from January 2014 to December 2019. An abnormal short-term outcome was defined as any one of the following seizures or abnormal electroencephalography, abnormal brain magnetic resonance imaging obtained wi